The University of Southampton
University of Southampton Institutional Repository

Rapid and responsive health technology assessment: the development and evaluation process in the South and West region of England

Rapid and responsive health technology assessment: the development and evaluation process in the South and West region of England
Rapid and responsive health technology assessment: the development and evaluation process in the South and West region of England
The Development and Evaluation Committee (DEC) provides local guidance on the value of new and existing health care technologies, including drugs, devices, procedures and health care settings. The system is made up of two components: i) literature review and cost‐effectiveness estimation of the proposed and current technologies, and ii) consideration by the Development and Evaluation Committee which arbitrates, makes recommendations and disseminates results across the South and West region. Sixty‐three reviews have been undertaken to date, including, for example, beta interferon for multiple sclerosis, pulsed dye laser in the treatment of port‐wine stains, and paclitaxel in ovarian cancer. The outcomes of this service are guides to purchasing which are both carefully researched and scrutinized.
1361-5874
51-56
Best, Lesley
7c4a1fe5-21a1-4634-a1cc-0230322603d1
Stevens, Andrew
e4ad8d5c-5041-4eaf-be50-1baa36e3ed47
Colin-Jones, Duncan
53045e55-776a-40bd-b4d8-8067a42a677a
Best, Lesley
7c4a1fe5-21a1-4634-a1cc-0230322603d1
Stevens, Andrew
e4ad8d5c-5041-4eaf-be50-1baa36e3ed47
Colin-Jones, Duncan
53045e55-776a-40bd-b4d8-8067a42a677a

Best, Lesley, Stevens, Andrew and Colin-Jones, Duncan (1997) Rapid and responsive health technology assessment: the development and evaluation process in the South and West region of England. Journal of Clinical Effectiveness, 2 (2), 51-56. (doi:10.1108/eb020865).

Record type: Article

Abstract

The Development and Evaluation Committee (DEC) provides local guidance on the value of new and existing health care technologies, including drugs, devices, procedures and health care settings. The system is made up of two components: i) literature review and cost‐effectiveness estimation of the proposed and current technologies, and ii) consideration by the Development and Evaluation Committee which arbitrates, makes recommendations and disseminates results across the South and West region. Sixty‐three reviews have been undertaken to date, including, for example, beta interferon for multiple sclerosis, pulsed dye laser in the treatment of port‐wine stains, and paclitaxel in ovarian cancer. The outcomes of this service are guides to purchasing which are both carefully researched and scrutinized.

This record has no associated files available for download.

More information

Published date: June 1997

Identifiers

Local EPrints ID: 485572
URI: http://eprints.soton.ac.uk/id/eprint/485572
ISSN: 1361-5874
PURE UUID: 6acfba31-6492-477e-b369-d2086ebd3304
ORCID for Lesley Best: ORCID iD orcid.org/0000-0003-1489-3471

Catalogue record

Date deposited: 11 Dec 2023 17:35
Last modified: 18 Mar 2024 03:53

Export record

Altmetrics

Contributors

Author: Lesley Best ORCID iD
Author: Andrew Stevens
Author: Duncan Colin-Jones

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×